Similar articles for PMID: 30611716

Year	Number of Results
2010	2
2011	5
2012	11
2013	11
2014	9
2015	6
2016	12
2017	10
2018	10
2019	19
2020	22
2021	12
2022	24
2023	7
2024	0

1

EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells.

Laurenzana A, Margheri F, Biagioni A, Chillà A, Pimpinelli N, Ruzzolini J, Peppicelli S, Andreucci E, Calorini L, Serratì S, Del Rosso M, Fibbi G. Laurenzana A, et al. EBioMedicine. 2019 Jan;39:194-206. doi: 10.1016/j.ebiom.2018.12.024. Epub 2019 Jan 2. EBioMedicine. 2019. PMID: 30611716 Free PMC article.

2

Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression.

Molnár E, Garay T, Donia M, Baranyi M, Rittler D, Berger W, Tímár J, Grusch M, Hegedűs B. Molnár E, et al. Int J Mol Sci. 2019 Sep 11;20(18):4484. doi: 10.3390/ijms20184484. Int J Mol Sci. 2019. PMID: 31514305 Free PMC article.

3

Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting.

Carroll MJ, Parent CR, Page D, Kreeger PK. Carroll MJ, et al. BMC Cancer. 2019 Oct 31;19(1):1025. doi: 10.1186/s12885-019-6175-2. BMC Cancer. 2019. PMID: 31672130 Free PMC article.

4

Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells.

Delgado-Goñi T, Galobart TC, Wantuch S, Normantaite D, Leach MO, Whittaker SR, Beloueche-Babari M. Delgado-Goñi T, et al. Br J Cancer. 2020 Jan;122(1):72-81. doi: 10.1038/s41416-019-0628-x. Epub 2019 Dec 10. Br J Cancer. 2020. PMID: 31819183 Free PMC article.

5

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.

Sun C, Wang L, Huang S, Heynen GJ, Prahallad A, Robert C, Haanen J, Blank C, Wesseling J, Willems SM, Zecchin D, Hobor S, Bajpe PK, Lieftink C, Mateus C, Vagner S, Grernrum W, Hofland I, Schlicker A, Wessels LF, Beijersbergen RL, Bardelli A, Di Nicolantonio F, Eggermont AM, Bernards R. Sun C, et al. Nature. 2014 Apr 3;508(7494):118-22. doi: 10.1038/nature13121. Epub 2014 Mar 26. Nature. 2014. PMID: 24670642 Free article.

6

Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.

Acquaviva J, Smith DL, Jimenez JP, Zhang C, Sequeira M, He S, Sang J, Bates RC, Proia DA. Acquaviva J, et al. Mol Cancer Ther. 2014 Feb;13(2):353-63. doi: 10.1158/1535-7163.MCT-13-0481. Epub 2014 Jan 7. Mol Cancer Ther. 2014. PMID: 24398428

7

Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.

Girotti MR, Pedersen M, Sanchez-Laorden B, Viros A, Turajlic S, Niculescu-Duvaz D, Zambon A, Sinclair J, Hayes A, Gore M, Lorigan P, Springer C, Larkin J, Jorgensen C, Marais R. Girotti MR, et al. Cancer Discov. 2013 Feb;3(2):158-67. doi: 10.1158/2159-8290.CD-12-0386. Epub 2012 Dec 14. Cancer Discov. 2013. PMID: 23242808 Free PMC article.

8

Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment.

Dratkiewicz E, Simiczyjew A, Pietraszek-Gremplewicz K, Mazurkiewicz J, Nowak D. Dratkiewicz E, et al. Int J Mol Sci. 2019 Dec 23;21(1):113. doi: 10.3390/ijms21010113. Int J Mol Sci. 2019. PMID: 31877948 Free PMC article.

9

BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAF^V600E Mutant Melanoma.

Kulkarni A, Al-Hraishawi H, Simhadri S, Hirshfield KM, Chen S, Pine S, Jeyamohan C, Sokol L, Ali S, Teo ML, White E, Rodriguez-Rodriguez L, Mehnert JM, Ganesan S. Kulkarni A, et al. Clin Cancer Res. 2017 Sep 15;23(18):5631-5638. doi: 10.1158/1078-0432.CCR-16-0758. Epub 2017 May 24. Clin Cancer Res. 2017. PMID: 28539463

10

HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E.

Chang X, Zhang T, Wang Q, Rathore MG, Reddy K, Chen H, Shin SH, Ma WY, Bode AM, Dong Z. Chang X, et al. Theranostics. 2020 Aug 1;10(21):9721-9740. doi: 10.7150/thno.44342. eCollection 2020. Theranostics. 2020. PMID: 32863956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

133 results

Results by year